Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury
Avalyn Pharma appointed Adam Golden as General Counsel and Head of Business Development and Frank Salisbury as Senior Vice President, Commercial to strengthen its leadership team. Golden brings over 30 years of legal and business development experience, while Salisbury offers 24 years of commercial expertise including the launch of FDA-approved therapies like ESBRIET.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.